Código QR (código de barras bidimensional)

Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination among Adults in the USA Aged 50–59 Years at Increased Risk of Severe RSV Disease

Abstract Introduction Adults with certain comorbidities, including metabolic and cardiopulmonary diseases, are at increased risk of severe respiratory syncytial virus (RSV) disease. We evaluated the cost-effectiveness of adjuvanted RSVPreF3 vaccination in adults in the USA aged 50–59 years at increa...

Fuld beskrivelse

Na minha lista:
Principais autores: David Singer, Elizabeth M. La, Jonathan Graham, Daniel Molnar, Mei Grace, Sara Poston, Frederik Verelst
Format: Artigo
Sprog:Inglês
Udgivet: Adis, Springer Healthcare 2025-10-01
Serier:Infectious Diseases and Therapy
Fag:
Adjuvanted RSVPreF3 vaccine
Adults
Cost-effectiveness
Respiratory syncytial virus
United States
Vaccination
Online adgang:https://doi.org/10.1007/s40121-025-01238-8
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker